Terms search
1
Heparin-Induced Thrombocytopenia
Theodore Warkentin (Editor); Andreas Greinacher (Editor)
2
Heparin-induced thrombocytopenia
Greinacher; Andreas; Warkentin; Theodore E
3
Therapeutic Advances in Thrombosis
Moliterno David J. (Ed.)
4
Therapeutic Advances in Thrombosis, Second Edition
David J. Moliterno; Steen Dalby Kristensen; Raffaele De Caterina
5
New Therapeutic Agents in Thrombosis and Thrombolysis
Jane E. Freedman; Joseph Loscalzo (eds.)
6
New therapeutic agents in thrombosis and thrombolysis
Jane E Freedman; Joseph Loscalzo
7
Therapeutic Strategies in Thrombosis
Steen Dalby Kristensen; Raffaele De Caterina; David J.; M.D. Moliterno
8
Heparin-Induced Thrombocytopenia, Fourth Edition (Fundamental and Clinical Cardiology)
Theodore E. Warkentin; Andreas Greinacher
9
Heparin-Induced Thrombocytopenia, Fourth Edition
Theodore E. Warkentin; Andreas Greinacher
10
Fondaparinux: does it cause HIT? can it treat HIT
Warkentin; Theodore E
11
Fondaparinux – data on efficacy and safety in special situations
Michael Nagler; Michael Haslauer; Walter A. Wuillemin
12
Anticoagulation Therapy: A Point-of-Care Guide
Dager; William E.; American Society of Health-System Pharmacists; Gulseth; Michael; Nutescu; Edith A.;
13
Inpatient Anticoagulation
Scott A. Flanders; Sanjay Saint(eds.)
14
Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease
Angiolillo Dominick; Adnan Kastrati; Daniel Simon
15
Antithrombotic Drug Therapy in Cardiovascular Disease
Edward F. Plow PHD; Peter Kelly MD (Author); Arman T. Askari; A. Michael Lincoff (Editors)
16
The Heparins: Basic and Clinical Aspects
David Green
17
Clinical Guide to the Use of Antithrombotic Drugs in Coronary Artery Disease
D. Angiolli; et. al.;
18
Pentasaccharides
Alexander G.G. Turpie
19
Evaluation of the pharmacological properties and clinical results of the synthetic pentasaccharide (fondaparinux)
Meyer-Michel Samama; Grigoris T. Gerotziafas
20
The synthetic pentasaccharide fondaparinux reduces coagulation, inflammation and neutrophil accumulation in kidney ischemia–reperfusion injury
R. D. FRANK; G. SCHABBAUER; T. HOLSCHER; Y. SATO; M. TENCATI; R. PAWLINSKI; N. MACKMAN
21
Fondaparinux, a Synthetic Pentasaccharide: The First in a New Class of Antithrombotic Agents — The Selective Factor Xa Inhibitors
Kenneth A. Bauer; David W. Hawkins; Paul C. Peters; Maurice Petitou; Jean-Marc Herbert; Constant A. A. van Boeckel; Dirk G. Meuleman
22
Recombinant factor VIIa reverses the in vitro and ex vivo anticoagulant and profibrinolytic effects of fondaparinux
T. Lisman; N. R. Bijsterveld; J. Adelmeijer; J. C. M. Meijers; M. Levi; H. K. Nieuwenhuis; P. G. De Groot
23
The design of venous thromboembolism prophylaxis trials: Fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery
A.G.G. Turpie
24
Severe bleeding secondary to misuse of fondaparinux: a case report
Hubert Nielly; Aurore Bousquet; Patrick Le Garlantezec; Eric Perrier; Xavier Bohand
25
The influence of fondaparinux on the diagnosis of postoperative deep vein thrombosis by soluble fibrin and D-dimer
Niimi; R.; Hasegawa; M.; Shi; D.Q.; Sudo; A
26
Fondaparinux: A new antithrombotic agent
Judy W.M. Cheng
27
Contemporary Hospitalists' Guide to Anticoagulation
Steven B. Deitelzweig; Alpesh N. Amin; M.D.
28
Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review
Subarna Thirugnanam; Ruxandra Pinto; Deborah J Cook; William H Geerts; Robert A Fowler
29
La maladie thrombo-embolique veineuse
Lacroix; Philippe
30
Development and in vivo bioavailability study of an oral fondaparinux delivery system
A. Vetter; G. Perera; K. Leithner; G. Klima; A. Bernkop-Schnürch
31
Minimizing costs for treating deep vein thrombosis: the role for fondaparinux
Andrew F. Shorr; William L. Jackson; Lisa K. Moores; Theodore E. Warkentin
32
Fondaparinux as a Treatment Option for Heparin-Induced Thrombocytopenia
Dr. Stella Papadopoulos; Dr. Jeremy D. Flynn; Dr. Daniel A. Lewis
33
Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series
T. E. WARKENTIN; M. PAI; J. I. SHEPPARD; S. SCHULMAN; A. C. SPYROPOULOS; J. W. EIKELBOOM
34
Pharmacological treatment of acute coronary syndromes
Jose Lopez-Sendón MD; PhD (auth.); Pablo Avanzas; Peter Clemmensen (eds.)
35
Pharmacological Treatment of Acute Coronary Syndromes
Jose Lopez-Sendón MD; PhD (auth.); Pablo Avanzas; Peter Clemmensen (eds.)
36
Thromboembolism in Orthopedic Surgery ||
Llau; Juan V
37
Application, tolerance and safety of fondaparinux therapy in a German hospital: A prospective single-centre experience
Marc Schindewolf; Julia Scheuermann; Hartmut Kroll; Ingo Marzi; Roland Kaufmann; Wolf-Henning Boehncke; Ralf J. Ludwig; Edelgard Lindhoff-Last
38
Thromboembolism in Orthopedic Surgery
Bengt I. Eriksson M.D.; Ph.D. (auth.); Juan V. Llau (eds.)
39
Fondaparinux : mise au point et perspectives
C. Garcia Hejl; C. Garcia; H. Thefenne-Astier; A. Servonnet; T. Samson; V. Foissaud
40
Antithrombotic Therapy for VTE Disease
Kearon; Clive
41
The status of new anticoagulants
Shannon M. Bates; Jeffrey I. Weitz
42
Fondaparinux: an update on new study results
R. M. Bauersachs
43
Klinische Hämostaseologie in der Gynäkologie und Geburtshilfe
Christoph Sucker; Sven Ackermann
